All lobbying filings

T1INTERNATIONAL USA

Lobbying for T1INTERNATIONAL USA

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Maine · House · Senate · posted Oct 15, 2025

Official filing document

Bills named in this filing 12

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
S 1040
Drug Competition Enhancement Act
S 1041
Affordable Prescriptions for Patients Act
S 1095
Stop STALLING Act
S 1096
Preserve Access to Affordable Generics and Biosimilars Act
HR 3160
PREVAIL Act
S 1553
PREVAIL Act
HR 3152
Patent Eligibility Restoration Act of 2025
S 1546
Patent Eligibility Restoration Act of 2025
S 1818
Prescription Drug Price Relief Act of 2025
S 1753
End Price Gouging for Medications Act
S 1218
Fair Prescription Drug Prices for Americans Act

Lobbying activity 1

Health Issues

Issues related to the following bills: oBig Beautiful Bill (HR 1) oDrug Competition Enhancement Act (S.1040) oAffordable Prescriptions for Patients Act (S.1041) oStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act (S.1095) oPreserve Access to Affordable Generics and Biosimilars Act (S.1096) oPromoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (H.R.3160/S.1553): oPatent Eligibility Restoration (PERA) Act (H.R.3152/S.1546) oPrescription Drug Price Relief Act (S.1818) oEnd Price Gouging for Medications Act (S.1753) oFair Prescription Drug Prices for Americans Act (S.1218)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.